Get started
Author

Sanadelaslam S. A. El‐Hddad

Observed names: SANADELASLAM EL-HDDAD, Sanad Elaslam S.A. El-Hddad, Sanadelaslam El-Hddad, Sanadelaslam S. A. El-Hddad, Sanadelaslam S.A. El-Hddad, Sanadelaslam SA El-Hddad
ORCID: 0000-0002-7183-6505
Observed ORCID: 0000-0002-7183-6505
OpenAlex ID: A5111179141
Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme
2020 · Khaled El-Adl, Abdel-Ghany A. El-Helby, et al. · Bioorganic Chemistry · 106
Design, synthesis, molecular docking, and anticancer evaluations of 1‐benzylquinazoline‐2,4(1H,3H)‐dione bearing different moieties as VEGFR‐2 inhibitors
2020 · Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, et al. · Archiv der Pharmazie · 60
Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5‐[(4‐chloro/2,4‐dichloro)benzylidene]thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibitors
2020 · Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, et al. · Archiv der Pharmazie · 58
Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists
2022 · Mohamed A. Abdelgawad, Khaled El-Adl, et al. · Pharmaceuticals · 57
PDF
Nanogel-mediated drug delivery system for anticancer agent: pH stimuli responsive poly(ethylene glycol/acrylic acid) nanogel prepared by gamma irradiation
2022 · Nour E.A. Abd El-Sattar, Sanad Elaslam S.A. El-Hddad, et al. · Bioorganic Chemistry · 50
Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibitors
2021 · Khaled El‐Adl, Helmy Sakr, et al. · Archiv der Pharmazie · 49
Five and six membered heterocyclic rings endowed with azobenzene as dual EGFR T790M and VEGFR-2 inhibitors: design, synthesis, in silico ADMET profile, molecular docking, dynamic simulation and anticancer evaluations
2023 · Kurls E. Anwer, Sanadelaslam S. A. El-Hddad, et al. · RSC Advances · 47
PDF
Design, synthesis, and docking of novel thiazolidine‐2,4‐dione multitarget scaffold as new approach for cancer treatment
2023 · Noura S. Hanafy, Nada A. A. M. Aziz, et al. · Archiv der Pharmazie · 28
PDF
Iodoquinazoline-derived VEGFR-2 and EGFRT790M dual inhibitors: Design, synthesis, molecular docking and anticancer evaluations
2023 · Abeer A. Mohamed, Sanadelaslam S.A. El-Hddad, et al. · Bioorganic Chemistry · 23
Aminopyridone-Linked Benzimidazoles: A Fragment-Based Drug Design for the Development of CDK9 Inhibitors
2023 · Ebtehal M Husseiny, Hamada S Abulkhair, et al. · Future Medicinal Chemistry · 17
In silico molecular docking, dynamics simulation and repurposing of some VEGFR-2 inhibitors based on the SARS-CoV-2-main-protease inhibitor N3
2022 · Sanadelaslam El-Hddad, Mohamed Sobhy, et al. · Journal of Biomolecular Structure and Dynamics · 15
Design, nanogel synthesis, anti-proliferative activity and in silico ADMET profile of pyrazoles and pyrimidines as topo-II inhibitors and DNA intercalators
2025 · Ahmed K. B. Aljohani, Sanadelaslam S. A. El-Hddad, et al. · RSC Advances · 12
PDF
Quinazolines and thiazolidine-2,4-dions as SARS-CoV-2 inhibitors: repurposing, in silico molecular docking and dynamics simulation
2024 · Sanadelaslam S. A. El-Hddad, Mohamed H. Sobhy, et al. · RSC Advances · 7
PDF
Phytochemical Screening, GC–MS Analysis, and Antibacterial Activity of Dittrichia graveolens (L.) Greuter
2025 · Salawa Eltawaty, Mohammed Suliman, et al. · Tropical Journal of Natural Product Research · 3
PDF
Exploration of cytotoxicity of iodoquinazoline derivatives as inhibitors of both VEGFR‐2 and EGFRT790M: Molecular docking, ADMET, design, and syntheses
2024 · Marwa Alsulaimany, Sanadelaslam S. A. El‐Hddad, et al. · Archiv der Pharmazie · 1
Quality of Amoxicillin Trihydrate/potassium Clavulanate Tablets Commercially Available in Libyan Pharmaceutical Market
2023 · SANADELASLAM EL-HDDAD, MOHAMMED B. SULIMAN · International Journal of Applied Pharmaceutics · 1
PDF
Comprehensive Phytochemical Profiling and Multi‐Target Biological Evaluation of Hibiscus sabdariffa L. Calyx Extracts From Libya: A Promising Functional Food Candidate With Antibacterial, Antioxidant, Anti‐Inflammatory, and Cytotoxic Properties: Validation Through In Silico Approaches
2026 · Ahmed Saeed Kabbashi, Zuhir S. Mussa Akrim, et al. · Food Science & Nutrition
Phytochemistry and Biological Activities of Hibiscus sabdariffa Leaf Extract: A Comprehensive Analysis and In Silico Approaches
2026 · Mohammed Babiker Suliman, Muna Ali Othman, et al. · Indonesian Journal of Chemistry
PDF
Author response for "Quinazolines and thiazolidine-2,4-dions as SARS-CoV-2 inhibitors: repurposing, in silico molecular docking and dynamics simulation"
2024 · Sanadelaslam S. A. El-Hddad, Mohamed H. Sobhy, et al. · Publons reviews and discussion
Works count: 19
Citation count: 534
H-index: 12
I10-index: 12
Year
Topic
Type